Euretos
Private Company
Total funding raised: $6.2M
Overview
Euretos is a private, revenue-generating AI/ML platform company founded in 2012 and headquartered in Utrecht, Netherlands. It has developed a sophisticated biological knowledge graph platform that integrates diverse data sources to accelerate target discovery, validation, and assessment for biopharma clients. The company has a proven track record, with its platform and services having contributed to approved drugs and active clinical trials across several therapeutic areas for multiple biopharma partners.
Technology Platform
AI-powered biological knowledge graph platform that integrates literature, patents, experimental data, and real-world patient data. It features predictive ML models for gene-disease associations, multi-criteria target ranking, single-cell expression analysis, and workflows for target discovery and assessment.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Euretos competes in the crowded AI-for-drug-discovery market against pure-play peers like BenevolentAI, Exscientia, and Recursion, as well as informatics giants like Elsevier and IQVIA. Its differentiation lies in its integrated knowledge graph approach, focus on user-friendly workflows for researchers, and a demonstrated track record of contributing to clinical-stage outcomes.